GM2 gangliosidoses in Spain: analysis of the HEXA and HEXB genes in 34 Tay-Sachs and 14 Sandhoff patients.

The GM2 gangliosidoses are autosomal recessive lysosomal storage diseases caused by a deficiency of the β-hexosaminidase A enzyme. This enzyme is composed of two polypeptide chains designated the α- and β- subunits and it interacts with the GM2 activator protein. The HEXA and HEXB genes encode the α-subunit and the β-subunit, respectively. Mutations in these genes are causative of Tay-Sachs disease (HEXA) and Sandhoff disease (HEXB). We analyzed the complete HEXA gene in 34 Spanish patients with Tay-Sachs disease and the HEXB gene in 14 Spanish patients with Sandhoff disease. We identified 27 different mutations, 14 of which were novel, in the HEXA gene and 14 different mutations, 8 of which unreported until now, in the HEXB gene, and we attempted to correlate these mutations with the clinical presentation of the patients. We found a high frequency of c.459+5G>A (IVS4+5G>A) mutation in HEXA affected patients, 22 of 68 alleles, which represent the 32.4%. This is the highest percentage found of this mutation in a population. All patients homozygous for mutation c.459+5G>A presented with the infantile form of the disease and, as previously reported, patients carrying mutation p.R178H in at least one of the alleles presented with a milder form. In HEXB affected patients, the novel deletion c.171delG accounts for 21.4% of the mutant alleles (6/28). All patients with this deletion showed the infantile form of the disease. The Spanish GM2 gangliosidoses affected patients show a great mutational heterogeneity as seen in other inherited lisosomal diseases in this country.

[1]  F. Alkuraya,et al.  GM2 gangliosidosis in Saudi Arabia: Multiple mutations and considerations for future carrier screening , 2011, American journal of medical genetics. Part A.

[2]  M. Natowicz,et al.  Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England. , 1995, American journal of human genetics.

[3]  L. Gort,et al.  Identification of 12 novel mutations and two new polymorphisms in the arylsulfatase A gene: Haplotype and genotype–phenotype correlation studies in spanish metachromatic leukodystrophy patients , 1999, Human mutation.

[4]  J. Tutor.  Biochemical characterization of the GM2 gangliosidosis B1 variant. , 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[5]  S. Tsuji,et al.  A novel exon mutation in the human beta-hexosaminidase beta subunit gene affects 3' splice site selection. , 1992, The Journal of biological chemistry.

[6]  K. Vlahovicek,et al.  Molecular analysis of the HEXA gene in Italian patients with infantile and late Onset Tay‐Sachs disease: detection of fourteen novel alleles , 2005, Human mutation.

[7]  K. Vlahovicek,et al.  Molecular and functional analysis of the HEXB gene in Italian patients affected with Sandhoff disease: identification of six novel alleles , 2009, neurogenetics.

[8]  S. Schuster,et al.  Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests. , 1990, The New England journal of medicine.

[9]  K. Ohno,et al.  Mutation in GM2‐Gangliosidosis B1 Variant , 1988, Journal of neurochemistry.

[10]  M. Zwarts,et al.  New cases of adult-onset Sandhoff disease with a cerebellar or lower motor neuron phenotype , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  J. Zieleński,et al.  A mutation common in non‐jewish Tay–Sachs disease: Frequency and RNA studies , 1992, Human mutation.

[12]  A. Levit,et al.  Two novel exonic point mutations in HEXA identified in a juvenile Tay-Sachs patient: role of alternative splicing and nonsense-mediated mRNA decay. , 2010, Molecular genetics and metabolism.

[13]  R. Myerowitz,et al.  The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase. , 1988, The Journal of biological chemistry.

[14]  G. Isshiki,et al.  Molecular genetics of Tay-Sachs disease in Japan , 1994, Journal of Inherited Metabolic Disease.

[15]  A. Salviati,et al.  A novel 4-bp deletion creates a premature stop codon and dramatically decreases HEXB mRNA levels in a severe case of Sandhoff disease. , 2001, Molecular and cellular probes.

[16]  F. Baas,et al.  Molecular basis of an adult form of Sandhoff disease: substitution of glutamine for arginine at position 505 of the beta-chain of beta-hexosaminidase results in a labile enzyme. , 1993, Biochimica et biophysica acta.

[17]  M. Martínez-Pardo,et al.  Genetic and phenotypic aspects of phenylalanine hydroxylase deficiency in Spain: molecular survey by regions , 1999, European Journal of Human Genetics.

[18]  B. Paw,et al.  Frequency of three Hex A mutant alleles among Jewish and non-Jewish carriers identified in a Tay-Sachs screening program. , 1990, American journal of human genetics.

[19]  J. Chelly,et al.  Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments. , 1991, Genomics.

[20]  E. Schaftingen,et al.  Biochemical and molecular studies in 26 Spanish patients with congenital disorder of glycosylation type Ia , 2003, Journal of Inherited Metabolic Disease.

[21]  I. Rivera,et al.  The correlation of genotype and phenotype in Portuguese hyperphenylalaninemic patients. , 2000, Molecular genetics and metabolism.

[22]  G. Charria-Ortiz.  The GM2 Gangliosidoses , 2007 .

[23]  T. Nakano,et al.  Genetic cause of a juvenile form of Sandhoff disease. Abnormal splicing of beta-hexosaminidase beta chain gene transcript due to a point mutation within intron 12. , 1989, The Journal of biological chemistry.

[24]  A. Chabás,et al.  Allelic heterogeneity in Spanish patients with Sanfilippo disease type B. Identification of eight new mutations , 2001, Journal of Inherited Metabolic Disease.

[25]  R. Proia,et al.  The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease. , 1989, Science.

[26]  D. Wenger,et al.  Usefulness of 4‐methylumbelliferyl‐6‐ sulfo‐2‐acetamido‐2‐deoxy‐β‐D‐glucopyranoside for the diagnosis of GM2 gangliosidoses in leukocytes , 1984, Clinical genetics.

[27]  D. Mahuran,et al.  Structure and distribution of an Alu-type deletion mutation in Sandhoff disease. , 1990, The Journal of clinical investigation.

[28]  Beth McInnes,et al.  Two small deletion mutations of the HEXB gene are present in DNA from a patient with infantile Sandhoff disease. , 1992, Biochimica et biophysica acta.

[29]  M. Ribeiro,et al.  GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene mutations in 11 patients from a defined region in Portugal. , 1991, American journal of human genetics.

[30]  K. Vlahovicek,et al.  Molecular analysis of HEXA gene in Argentinean patients affected with Tay-Sachs disease: possible common origin of the prevalent c.459+5A>G mutation. , 2012, Gene.

[31]  I. Rivera,et al.  Mutational spectrum of classical galactosaemia in Spain and Portugal , 2006, Journal of Inherited Metabolic Disease.

[32]  G. Thomas,et al.  Six novel deleterious and three neutral mutations in the gene encoding the alpha-subunit of hexosaminidase A in non-Jewish individuals. , 1992, American journal of human genetics.

[33]  M. Mcginniss,et al.  Eight novel mutations in the HEXA gene , 2002, Genetics in Medicine.

[34]  E. Andermann,et al.  The intron 7 donor splice site transition: a second Tay-Sachs disease mutation in French Canada , 1992, Human Genetics.

[35]  H. Kresse,et al.  Liberation of N-acetylglucosamine-6-sulfate by human beta-N-acetylhexosaminidase A. , 1981, The Journal of biological chemistry.

[36]  X. Estivill,et al.  Mutational spectrum of phenylalanine hydroxylase deficiency in the population resident in Catalonia: genotype-phenotype correlation , 1999, Human Genetics.

[37]  D. Grinberg,et al.  Molecular analysis of 30 Niemann–Pick type C patients from Spain , 2011, Clinical genetics.

[38]  J. Clarke,et al.  Sequence of DNA flanking the exons of the HEXA gene, and identification of mutations in Tay-Sachs disease. , 1991, American journal of human genetics.

[39]  R. Proia,et al.  Tay-Sachs disease in Moroccan Jews: deletion of a phenylalanine in the alpha-subunit of beta-hexosaminidase. , 1991, American journal of human genetics.

[40]  D. Mahuran,et al.  Characterization of two HEXB gene mutations in Argentinean patients with Sandhoff disease. , 1992, Biochimica et biophysica acta.

[41]  N. Hogikyan,et al.  Different mutations in Ashkenazi Jewish and non-Jewish French Canadians with Tay-Sachs disease. , 1986, Science.